Avenue Therapeutics, Inc. Gains 22.67%

Mon, Jul 18, 2022 at 07:09 PM
Avenue Therapeutics, Inc. Gains 22.67%

Avenue Therapeutics, Inc. (ATXI:NASDAQ) rocketted at $0.32, representing a gain of 22.7%. On Mon, Jul 18, 2022, ATXI:NASDAQ touched a New 2-Week High of $0.32. From Tue, Jul 05, 2022, the stock recorded 22.22% Up Days and 40.00% Green Days

The stock spiked on Wed, Jun 29, 2022 at $0.4 with a volume of 3M+.

About Avenue Therapeutics, Inc. (ATXI:NASDAQ)

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.